Abstract The 2020 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice
Guideline on the Evaluation and Management of Candidates for Kidney Transplantation is …

Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common
complications affecting solid organ transplant recipients, conveying higher risks of …

The introduction and broad use of new immunosuppressive agents, including biologic
agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease …

The prevention, diagnosis, and management of infectious disease in transplantation are
major contributors to improved outcomes in organ transplantation. The risk of serious …

The first human orthotopic liver transplantation (LT) in Europe was performed by Sir Roy
Calne in Cambridge in 1968 [1], only one year after the first successful human liver …

Short-term patient and graft outcomes continue to improve after kidney and liver
transplantation, with 1-year survival rates over 80%; however, improving longer-term …

Cytomegalovirus infection is a frequent complication after transplantation. This infection
occurs due to transmission from the transplanted organ, due to reactivation of latent …

Infection is a major cause of morbidity and mortality in patients with chronic kidney disease
(CKD), including those receiving maintenance dialysis or with a kidney transplant. Although …

These guidelines cover the care of patients from the period following kidney transplantation
until the transplant is no longer working or the patient dies. During the early phase …

Background Maribavir is a benzimidazole riboside with activity against cytomegalovirus
(CMV). The safety and efficacy of maribavir for preemptive treatment of CMV infection in …